Lexicon Pharmaceuticals
LXRX
#6234
Rank
A$1.43 B
Marketcap
A$3.24
Share price
-1.74%
Change (1 day)
76.46%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -A$39.07 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are A$69.64 Million. In 2025 the company made an earning of -A$72.1 Million, an increase over its 2024 earnings that were of -A$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$39.07 Million-45.81%
2025 -A$72.1 Million-74.88%
2024 -A$0.29 Billion13.15%
2023 -A$0.26 Billion73.74%
2022 -A$0.15 Billion16.16%
2021 -A$0.13 Billion49.82%
2020 -A$83.89 Million-147.19%
2019 A$0.17 B-203.42%
2018 -A$0.18 Billion-15.31%
2017 -A$0.21 Billion0.2%
2016 -A$0.21 Billion2920.7%
2015 -A$6.71 Million-95.33%
2014 -A$0.15 Billion-3.61%
2013 -A$0.15 Billion-5.52%
2012 -A$0.16 Billion-4.17%
2011 -A$0.17 Billion15.5%
2010 -A$0.15 Billion8.36%
2009 -A$0.14 Billion-4.81%
2008 -A$0.14 Billion28.79%
2007 -A$0.11 Billion35.71%
2006 -A$79.1 Million52.91%
2005 -A$51.73 Million-23.89%
2004 -A$67.96 Million-24.19%
2003 -A$89.64 Million-0.48%
2002 -A$90.07 Million44.12%
2001 -A$62.5 Million23.01%
2000 -A$50.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
A$10.62 B-28,547.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.66 B-4,546.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.38 B-19,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-A$0.77 Billion 1,956.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.27 B-830.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.11 B-404.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$33.29 Million-10.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.55 B-1,577.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$21.37 Million-42.82%๐Ÿ‡บ๐Ÿ‡ธ USA